You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 276 No. 22, December 11, 1996 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer

John J. Albertini, MD; Gary H. Lyman, MD, MPH; Charles Cox, MD; Tim Yeatman, MD; Ludovico Balducci, MD; NiNi Ku, MD; Steve Shivers, PhD; Claudia Berman, MD; Karen Wells, MD; David Rapaport, MD; Alan Shons, MD; John Horton, MB, ChB; Harvey Greenberg, MD; Santo Nicosia, MD; Robert Clark, MD; Alan Cantor, PhD; Douglas S. Reintgen, MD

JAMA. 1996;276(22):1818-1822.


Abstract

Objective.
—To identify the sentinel lymph node(s) (SLN[s]) (the first node[s] draining the primary tumor in the regional lymphatic basin) in patients with invasive breast cancer and to test the hypothesis that the histologic characteristics of the SLN predict the histologic characteristics of the remaining lymph nodes in the axilla.

Design.
—A prospective trial.

Participants.
—Sixty-two patients with newly diagnosed invasive breast cancers.

Intervention.
—Patients underwent intraoperative lymphatic mapping using a combination of a vital blue dye and filtered technetium-labeled sulfur colloid. The SLN was identified and removed, followed by a definitive cancer operation, including a complete axillary node dissection.

Main Outcome Measure.
—The metastatic distribution in the axilla was determined in patients with occult nodal disease.

Results.
—The SLN was successfully identified in 57 (92%) of 62 patients using the 2 lymphatic mapping procedures. After localization, 18 patients (32%) were found to have metastatic disease, and the SLN tested positive in all 18 patients. There were no "skip" metastases, defined as an SLN that tested negative with higher nodes that tested positive. In 12 (67%) of 18 patients with metastatic disease, the SLN was the only site of disease. The metastatic distribution significantly favored SLN involvement. Among subjects with discordant nodal involvement, the probability of observing the distribution of SLN involvement by chance is very small (P<.001).

Conclusions.
—This study confirms that lymphatic mapping is technically possible in the patient with breast cancer and that the histologic characteristics of the SLN probably reflect the histologic characteristics of the rest of the axillary lymph nodes. The procedure also allows the pathologist to focus the histologic examination on 1 or 2 nodes, potentially increasing the yield of positive dissections and the accuracy of staging.



Author Affiliations

From the Comprehensive Breast Cancer Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa.


Footnotes

Reprints: Douglas S. Reintgen, MD, Cutaneous Oncology, Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr, Tampa, FL 33612-9497.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial
Canavese et al.
Ann Oncol 2009;20:1001-1007.
ABSTRACT | FULL TEXT  

The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 1--Overview, Detection, and Staging
Lee et al.
JNM 2009;50:569-581.
ABSTRACT | FULL TEXT  

Commentary on in-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure
Cserni
J. Clin. Pathol. 2008;61:1233-1235.
FULL TEXT  

Is the "10% Rule" Equally Valid for All Subsets of Sentinel-Node-Positive Breast Cancer Patients?
Chung et al.
Ann. Surg. Oncol. 2008;15:2728-2733.
ABSTRACT | FULL TEXT  

A Scoring System to Predict Nonsentinel Lymph Node Status in Breast Cancer Patients with Metastatic Sentinel Lymph Nodes: A Comparison with Other Scoring Systems
Cho et al.
Ann. Surg. Oncol. 2008;15:2278-2286.
ABSTRACT | FULL TEXT  

Management of the Axilla in Women With Breast Cancer: Current Clinical Practice and a New Selective Targeted Approach
Samphao et al.
Ann. Surg. Oncol. 2008;15:1282-1296.
ABSTRACT | FULL TEXT  

Sentinel Node Positivity Rates With and Without Frozen Section for Breast Cancer
Arora et al.
Ann. Surg. Oncol. 2008;15:256-261.
ABSTRACT | FULL TEXT  

Sentinel Lymph Node Biopsy Performed After Neoadjuvant Chemotherapy is Accurate in Patients with Documented Node-Positive Breast Cancer at Presentation
Newman et al.
Ann. Surg. Oncol. 2007;14:2946-2952.
ABSTRACT | FULL TEXT  

Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011
Lucci et al.
JCO 2007;25:3657-3663.
ABSTRACT | FULL TEXT  

Validation and Limitations of Use of a Breast Cancer Nomogram Predicting the Likelihood of Non Sentinel Node Involvement After Positive Sentinel Node Biopsy
Alran et al.
Ann. Surg. Oncol. 2007;14:2195-2201.
ABSTRACT | FULL TEXT  

Neoadjuvant Docetaxel and Capecitabine and the Use of Thymidine Phosphorylase as a Predictive Biomarker in Breast Cancer
Layman et al.
Clin. Cancer Res. 2007;13:4092-4097.
ABSTRACT | FULL TEXT  

Breast Cancer Sentinel Lymph Node Identification Rates: The Influence of Radiocolloid Mapping, Case Volume, and the Place of the Procedure
Nathanson et al.
Ann. Surg. Oncol. 2007;14:1629-1637.
ABSTRACT | FULL TEXT  

The Utility of Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer
Pugliese et al.
Ann. Surg. Oncol. 2007;14:1024-1030.
ABSTRACT | FULL TEXT  

Feasibility of Breast Preserving Therapy with Single Fraction In Situ Radiotherapy Delivered Intraoperatively
Ollila et al.
Ann. Surg. Oncol. 2007;14:660-669.
ABSTRACT | FULL TEXT  

Sentinel Node Biopsy Using Dye and Isotope Double Tracers in Early Gastric Cancer
Lee et al.
Ann. Surg. Oncol. 2006;13:1168-1174.
ABSTRACT | FULL TEXT  

Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications
Chen et al.
CA Cancer J Clin 2006;56:292-309.
ABSTRACT | FULL TEXT  

Multicentric Breast Cancer: A New Indication for Sentinel Node Biopsy--A Multi-Institutional Validation Study
Knauer et al.
JCO 2006;24:3374-3380.
ABSTRACT | FULL TEXT  

Invasive Squamous Cell Carcinoma of the Skin: Defining a High-Risk Group
Mullen et al.
Ann. Surg. Oncol. 2006;13:902-909.
ABSTRACT | FULL TEXT  

Three-Axillary Lymph Node Sampling for the Prediction of Nonsentinel Node Metastases in Breast Cancer Patients With Sentinel Node Metastases
Motomura et al.
Ann. Surg. Oncol. 2006;13:985-989.
ABSTRACT | FULL TEXT  

Organ and Fetal Absorbed Dose Estimates from 99mTc-Sulfur Colloid Lymphoscintigraphy and Sentinel Node Localization in Breast Cancer Patients
Pandit-Taskar et al.
JNM 2006;47:1202-1208.
ABSTRACT | FULL TEXT  

A Further Validation of Subareolar Injection Technique for Breast Sentinel Lymph Node Biopsy
D'Eredita et al.
Ann. Surg. Oncol. 2006;13:701-707.
ABSTRACT | FULL TEXT  

Sentinel Node Biopsy Before Neoadjuvant Chemotherapy for Determining Axillary Status and Treatment Prognosis in Locally Advanced Breast Cancer
Cox et al.
Ann. Surg. Oncol. 2006;13:483-490.
ABSTRACT | FULL TEXT  

Axillary Ultrasonography to Detect Recurrence After Sentinel Node Biopsy in Breast Cancer
Snider et al.
Ann. Surg. Oncol. 2006;13:501-507.
ABSTRACT | FULL TEXT  

HER-2/neu Expression in Primary Breast Cancer With Sentinel Lymph Node Metastasis
Nathanson et al.
Ann. Surg. Oncol. 2006;13:205-213.
ABSTRACT | FULL TEXT  

Clinicopathologic Features Associated With Having Four or More Metastatic Axillary Nodes in Breast Cancer Patients With a Positive Sentinel Lymph Node
Rivers et al.
Ann. Surg. Oncol. 2006;13:36-44.
ABSTRACT | FULL TEXT  

American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
Lyman et al.
JCO 2005;23:7703-7720.
ABSTRACT | FULL TEXT  

Sentinel Lymph Node Biopsy for Breast Cancer: Will Variations in Technique Influence Long-Term Outcome?
Newman
Ann. Surg. Oncol. 2005;12:686-688.
FULL TEXT  

Comprehensive Axillary Evaluation in Neoadjuvant Chemotherapy Patients With Ultrasonography and Sentinel Lymph Node Biopsy
Khan et al.
Ann. Surg. Oncol. 2005;12:697-704.
ABSTRACT | FULL TEXT  

Contrast-Enhanced Sonographic Imaging of Lymphatic Channels and Sentinel Lymph Nodes
Goldberg et al.
J Ultrasound Med 2005;24:953-965.
ABSTRACT | FULL TEXT  

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27
Mamounas et al.
JCO 2005;23:2694-2702.
ABSTRACT | FULL TEXT  

Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes
Stathopoulos et al.
Ann Oncol 2005;16:240-246.
ABSTRACT | FULL TEXT  

Development of axillary surgery in breast cancer
Luini et al.
Ann Oncol 2005;16:259-262.
ABSTRACT | FULL TEXT  

Sentinel Lymph Node Metastases Detected by Immunohistochemistry Only Do Not Mandate Complete Axillary Lymph Node Dissection in Breast Cancer
Gray et al.
Ann. Surg. Oncol. 2004;11:1056-1060.
ABSTRACT | FULL TEXT  

Intraoperative Examination of Sentinel Nodes in Breast Cancer: Is the Glass Half Full or Half Empty?
Fortunato et al.
Ann. Surg. Oncol. 2004;11:1005-1010.
ABSTRACT | FULL TEXT  

Prognostic and Predictive Factors in Early-Stage Breast Cancer
Cianfrocca and Goldstein
The Oncologist 2004;9:606-616.
ABSTRACT | FULL TEXT  

Sentinel lymph node biopsy in breast cancer patients after overnight migration of radiolabelled sulphur colloid
Lamichhane et al.
Postgrad. Med. J. 2004;80:546-550.
ABSTRACT | FULL TEXT  

Sentinel Lymph Node Mapping of the Colon and Stomach Using Lymphoseek in a Pig Model
Ellner et al.
Ann. Surg. Oncol. 2004;11:674-681.
ABSTRACT | FULL TEXT  

Manipulation of the Primary Breast Tumor and the Incidence of Sentinel Node Metastases From Invasive Breast Cancer
Hansen et al.
Arch Surg 2004;139:634-640.
ABSTRACT | FULL TEXT  

Sentinel Lymph Nodes in a Swine Model with Melanoma: Contrast-enhanced Lymphatic US
Goldberg et al.
Radiology 2004;230:727-734.
ABSTRACT | FULL TEXT  

Paradigm of Metastasis for Melanoma and Breast Cancer Based on the Sentinel Lymph Node Experience
Leong
Ann. Surg. Oncol. 2004;11:192S-197S.
ABSTRACT | FULL TEXT  

Novel Techniques in Sentinel Lymph Node Mapping and Localization of Nonpalpable Breast Lesions: The Moffitt Experience
Cox et al.
Ann. Surg. Oncol. 2004;11:222S-226S.
ABSTRACT | FULL TEXT  

Sentinel Node Biopsy for High-Risk Nonmelanoma Cutaneous Malignancy
Wagner et al.
Arch Dermatol 2004;140:75-79.
ABSTRACT | FULL TEXT  

A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy
Van Zee et al.
Ann. Surg. Oncol. 2003;10:1140-1151.
ABSTRACT | FULL TEXT  

Pulse Oximeter Changes With Sentinel Lymph Node Biopsy in Breast Cancer
El-Tamer et al.
Arch Surg 2003;138:1257-1260.
ABSTRACT | FULL TEXT  

Emergence of Sentinel Node Biopsy in Breast Cancer as Standard-of-Care in Academic Comprehensive Cancer Centers
Edge et al.
JNCI J Natl Cancer Inst 2003;95:1514-1521.
ABSTRACT | FULL TEXT  

Subareolar Injection May Be More Accurate Than Other Techniques for Sentinel Lymph Node Biopsy in Breast Cancer
D'Eredita' et al.
Ann. Surg. Oncol. 2003;10:942-947.
ABSTRACT | FULL TEXT  

A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer
Veronesi et al.
NEJM 2003;349:546-553.
ABSTRACT | FULL TEXT  

Lymphatic Mapping and Sentinel Lymphadenectomy After Preoperative Therapy for Stage II and III Breast Cancer
Balch et al.
Ann. Surg. Oncol. 2003;10:616-621.
ABSTRACT | FULL TEXT  

Macroscopic Quality Control Improves the Reliability of Blue Dye-Only Sentinel Lymph Node Biopsy in Breast Cancer
Nos et al.
Ann. Surg. Oncol. 2003;10:525-530.
ABSTRACT | FULL TEXT  

Lymphoseek: A Molecular Radiopharmaceutical for Sentinel Node Detection
Wallace et al.
Ann. Surg. Oncol. 2003;10:531-538.
ABSTRACT | FULL TEXT  

Relapse and Morbidity in Patients Undergoing Sentinel Lymph Node Biopsy Alone or With Axillary Dissection for Breast Cancer
Blanchard et al.
Arch Surg 2003;138:482-488.
ABSTRACT | FULL TEXT  

Methylene Blue Dye as an Alternative to Isosulfan Blue Dye for Sentinel Lymph Node Localization
Simmons et al.
Ann. Surg. Oncol. 2003;10:242-247.
ABSTRACT | FULL TEXT  

Clinicopathologic Factors Predicting Involvement of Nonsentinel Axillary Nodes in Women With Breast Cancer
Hwang et al.
Ann. Surg. Oncol. 2003;10:248-254.
ABSTRACT | FULL TEXT  

A New Agent, Blue and Radioactive, for Sentinel Node Detection
El-Tamer et al.
Ann. Surg. Oncol. 2003;10:323-329.
ABSTRACT | FULL TEXT  

Current Status of Sentinel Lymph Node Mapping and Biopsy: Facts and Controversies
Jakub et al.
The Oncologist 2003;8:59-68.
ABSTRACT | FULL TEXT  

Retrospective Analysis of Sentinel Node Localization in Multifocal, Multicentric, Palpable, or Nonpalpable Breast Cancer
Kumar et al.
JNM 2003;44:7-10.
ABSTRACT | FULL TEXT  

Axillary Dissection Is Not Required for All Patients With Breast Cancer and Positive Sentinel Nodes
Guenther et al.
Arch Surg 2003;138:52-56.
ABSTRACT | FULL TEXT  

The Clinical Significance of Cytokeratin-Positive Cells in Lymph Nodes at the Time of Mastectomy From Patients With Ductal Carcinoma-In-Situ
Tamhane et al.
Ann. Surg. Oncol. 2002;9:999-1003.
ABSTRACT | FULL TEXT  

Comparison of Side Effects Between Sentinel Lymph Node and Axillary Lymph Node Dissection for Breast Cancer
Swenson et al.
Ann. Surg. Oncol. 2002;9:745-753.
ABSTRACT | FULL TEXT  

The Time Has Come to Change the Algorithm for the Surgical Management of Early Breast Cancer
Hansen et al.
Arch Surg 2002;137:1131-1135.
ABSTRACT | FULL TEXT  

Validation of Sentinel Node Mapping in Patients With Colon Cancer
Paramo et al.
Ann. Surg. Oncol. 2002;9:550-554.
ABSTRACT | FULL TEXT  

The role of tumor lymphangiogenesis in metastatic spread
STACKER et al.
FASEB J. 2002;16:922-934.
ABSTRACT | FULL TEXT  

Biology of Lymphatic Metastases in Breast Cancer: Lessons Learned From Sentinel Node Biopsy
Quan et al.
Ann. Surg. Oncol. 2002;9:467-471.
ABSTRACT | FULL TEXT  

Laparoscopic Sentinel Node Procedure in Patients With Cervical Cancer
Barranger et al.
JCO 2002;20:2602-2603.
FULL TEXT  

Utilization of Sentinel Lymph Node Mapping to Determine Pathologic Outcomes for Patients Receiving Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
Bland
Ann. Surg. Oncol. 2002;9:217-219.
FULL TEXT  

Analysis of Sentinel Lymph Node Mapping With Immediate Pathologic Review in Patients Receiving Preoperative Chemotherapy for Breast Carcinoma
Miller et al.
Ann. Surg. Oncol. 2002;9:243-247.
ABSTRACT | FULL TEXT  

The Effect of Prior Breast Biopsy Method and Concurrent Definitive Breast Procedure on Success and Accuracy of Sentinel Lymph Node Biopsy
Wong et al.
Ann. Surg. Oncol. 2002;9:272-277.
ABSTRACT | FULL TEXT  

Subareolar and Peritumoral Injection Identify Similar Sentinel Nodes for Breast Cancer
Bauer et al.
Ann. Surg. Oncol. 2002;9:169-176.
ABSTRACT | FULL TEXT  

Subareolar Injection of 99mTc Facilitates Sentinel Lymph Node Identification
Tuttle et al.
Ann. Surg. Oncol. 2002;9:77-81.
ABSTRACT | FULL TEXT  

Detection of Locoregional and Distant Recurrences in Breast Cancer Patients by Using FDG PET
Eubank et al.
RadioGraphics 2002;22:5-17.
ABSTRACT | FULL TEXT  

The Problem of the Accuracy of Intraoperative Examination of Axillary Sentinel Nodes in Breast Cancer
Zurrida et al.
Ann. Surg. Oncol. 2001;8:817-820.
ABSTRACT | FULL TEXT  

Utility of Breast Sentinel Lymph Node Biopsy Using Day-Before-Surgery Injection of High-Dose 99mTc-Labeled Sulfur Colloid
Solorzano et al.
Ann. Surg. Oncol. 2001;8:821-827.
ABSTRACT | FULL TEXT  

Pathways of Lymphatic Drainage From the Breast
Nathanson et al.
Ann. Surg. Oncol. 2001;8:837-843.
ABSTRACT | FULL TEXT  

Single Intralesional Tracer Dose for Radio-Guided Excision of Clinically Occult Breast Cancer and Sentinel Node
Tanis et al.
Ann. Surg. Oncol. 2001;8:850-855.
ABSTRACT | FULL TEXT  

Percutaneous Biopsy and Sentinel Lymphadenectomy: Minimally Invasive Diagnosis and Treatment of Nonpalpable Breast Cancer
Liberman and Cody
Am. J. Roentgenol. 2001;177:887-891.
ABSTRACT | FULL TEXT  

Occult Metastases in Sentinel Nodes of 200 Patients With Operable Breast Cancer
Dowlatshahi et al.
Ann. Surg. Oncol. 2001;8:675-681.
ABSTRACT | FULL TEXT  

Predictive Factors for Metastatic Involvement of Nonsentinel Nodes in Patients With Breast Cancer
Rahusen et al.
Arch Surg 2001;136:1059-1063.
ABSTRACT | FULL TEXT  

Highest Isotope Count Does Not Predict Sentinel Node Positivity in All Breast Cancer Patients
Martin et al.
Ann. Surg. Oncol. 2001;8:592-597.
ABSTRACT | FULL TEXT  

Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy
Cantin et al.
CMAJ 2001;165:166-173.
ABSTRACT | FULL TEXT  

Characteristics of the Sentinel Lymph Node in Breast Cancer Predict Further Involvement of Higher-Echelon Nodes in the Axilla: A Study to Evaluate the Need for Complete Axillary Lymph Node Dissection
Kamath et al.
Arch Surg 2001;136:688-692.
ABSTRACT | FULL TEXT  

The Role of Lymphoscintigraphy in the Management of the Patient With Breast Cancer
Dupont et al.
Ann. Surg. Oncol. 2001;8:354-360.
ABSTRACT | FULL TEXT  

Internal Mammary Lymph Node Drainage Patterns in Patients With Breast Cancer Documented by Breast Lymphoscintigraphy
Byrd et al.
Ann. Surg. Oncol. 2001;8:234-240.
ABSTRACT | FULL TEXT  

Esophageal Cancer: The Mode of Lymphatic Tumor Cell Spread and Its Prognostic Significance
Hosch et al.
JCO 2001;19:1970-1975.
ABSTRACT | FULL TEXT  

Lymphovascular Invasion Enhances the Prediction of Non-Sentinel Node Metastases in Breast Cancer Patients With Positive Sentinel Nodes
Weiser et al.
Ann. Surg. Oncol. 2001;8:145-149.
ABSTRACT | FULL TEXT  

Lymphoscintigraphy and Sentinel Node Localization in Breast Cancer Patients: A Comparison Between 1-Day and 2-Day Protocols
Yeung et al.
JNM 2001;42:420-423.
ABSTRACT | FULL TEXT  

Biopsy of Sentinel Lymph Nodes Guided by Lymphoscintigraphic Mapping in Patients with Breast Cancer
Tuthill et al.
Am. J. Roentgenol. 2001;176:407-411.
ABSTRACT | FULL TEXT  

Modification of the Sentinel Node Technique: It Was a Hit in New York, But Will It Play in Poughkeepsie?
Grube and Giuliano
Ann. Surg. Oncol. 2001;8:3-6.
FULL TEXT  

Localizing the Sentinel Node Outside of the Specialty Center: Success of a Lymphatic Mapping Course in Disseminating New Technology
Zervos et al.
Ann. Surg. Oncol. 2001;8:7-12.
ABSTRACT | FULL TEXT  

Complementarity of Blue Dye and Isotope in Sentinel Node Localization for Breast Cancer: Univariate and Multivariate Analysis of 966 Procedures
Cody III et al.
Ann. Surg. Oncol. 2001;8:13-19.
ABSTRACT | FULL TEXT  

Intradermal Isotope Injection: A Highly Accurate Method of Lymphatic Mapping in Breast Carcinoma
Boolbol et al.
Ann. Surg. Oncol. 2001;8:20-24.
ABSTRACT | FULL TEXT  

Sentinel Lymph Node Biopsy Is Accurate After Neoadjuvant Chemotherapy for Breast Cancer
Breslin et al.
JCO 2000;18:3480-3486.
ABSTRACT | FULL TEXT  

Axillary staging of breast cancer and the sentinel node
Cserni
J. Clin. Pathol. 2000;53:733-741.
ABSTRACT | FULL TEXT  

Selective Lymphoscintigraphy: A Necessary Adjunct to Dye-Directed Sentinel Node Biopsy for Breast Cancer?
Guenther et al.
Arch Surg 2000;135:1101-1105.
ABSTRACT | FULL TEXT  

Prospective Observational Study of Sentinel Lymphadenectomy Without Further Axillary Dissection in Patients With Sentinel Node-Negative Breast Cancer
Giuliano et al.
JCO 2000;18:2553-2559.
ABSTRACT | FULL TEXT  

Blue Nodes Left Behind After Vital Blue Dye-guided Axillary Sentinel Node Biopsy in Breast Cancer Patients
Cserni et al.
Jpn J Clin Oncol 2000;30:263-266.
ABSTRACT | FULL TEXT  

Microvessels That Predict Axillary Lymph Node Metastases in Patients With Breast Cancer
Nathanson et al.
Arch Surg 2000;135:586-594.
ABSTRACT | FULL TEXT  

Importance of Nuclear Morphology in Breast Cancer Prognosis
Wolberg et al.
Clin. Cancer Res. 1999;5:3542-3548.
ABSTRACT | FULL TEXT  

Sentinel Lymph Node Mapping for Breast Cancer: Analysis in a Diverse Patient Group
Eary et al.
Radiology 1999;213:526-529.
ABSTRACT | FULL TEXT  

The Learning Curve for Sentinel Node Biopsy in Breast Cancer: Practical Considerations
Orr et al.
Arch Surg 1999;134:764-767.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.